Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acumen Pharmaceuticals
Biotech
Ex-Eisai leader to be new NextPoint CEO—Chutes & Ladders
Ex-Eisai leader Cheung tapped as new NextPoint chief. Gregory to lead Regeneron's new cell therapy unit following 2seventy moves. Sanofi swaps CFOs.
Max Bayer
,
Gabrielle Masson
Feb 2, 2024 9:30am
Acumen posts early Alzheimer's data for next-gen Leqembi rival
Jul 17, 2023 5:32am
Acumen surges in IPO debut, raises $160M for Alzheimer's drug
Jul 1, 2021 2:43pm
Acumen prices IPO, targets phase 2 data on amyloid-beta prospect
Jun 25, 2021 8:30am
'Big hole' no more as Aduhelm opens AD drug funding 'floodgates'
Jun 10, 2021 11:03am
Acumen rides aducanumab, amyloid waves on its IPO voyage
Jun 10, 2021 9:50am
